Genomic profiling of a Hepatocyte growth factor-dependent signature for MET-targeted therapy in glioblastoma

BACKGROUND: Constitutive MET signaling promotes invasiveness in most primary and recurrent GBM. However, deployment of available MET-targeting agents is confounded by lack of effective biomarkers for selecting suitable patients for treatment. Because endogenous HGF overexpression often causes autocr...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:J Transl Med
Auteurs principaux: Johnson, Jennifer, Ascierto, Maria Libera, Mittal, Sandeep, Newsome, David, Kang, Liang, Briggs, Michael, Tanner, Kirk, Marincola, Francesco M., Berens, Michael E., Vande Woude, George F., Xie, Qian
Format: Artigo
Langue:Inglês
Publié: BioMed Central 2015
Sujets:
Research
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC4574608/
https://ncbi.nlm.nih.gov/pubmed/26381735
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12967-015-0667-x
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires